MERIL’s Myval THV Series Achieves Global Recognition in Heart Valve Sector at EuroPCR 2024
Bhubaneswar : Exciting news from Meril Life Sciences! The LANDMARK trials 30 days primary outcomes were presented on 15th May at EuroPCR 2024, Paris, France. LANDMARK was recognized by EuroPCR as one of the top three late breaking trials!-->…